Min Liao
Direttore/Membro del Consiglio presso Wuhan Canvest Biotechnology Co., Ltd.
Profilo
Min Liao is a Director at Wuhan Canvest Biotechnology Co., Ltd.
since 2019.
Previously, Mr. Liao worked as a Director at YingTong Telecommunication Co., Ltd.
Mr. Liao holds an MBA from City University of Macau.
Posizioni attive di Min Liao
Società | Posizione | Inizio |
---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Direttore/Membro del Consiglio | 17/09/2019 |
Precedenti posizioni note di Min Liao
Società | Posizione | Fine |
---|---|---|
YINGTONG TELECOMMUNICATION CO.,LTD. | Direttore/Membro del Consiglio | 09/01/2020 |
Formazione di Min Liao
City University of Macau | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
YINGTONG TELECOMMUNICATION CO.,LTD. | Commercial Services |
Aziende private | 1 |
---|---|
Wuhan Canvest Biotechnology Co., Ltd.
Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
- Borsa valori
- Insiders
- Min Liao